Skip to content

Clinical trials

Observational Cardiotoxicity trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiotoxicity Phase: Observational Country / region: United Kingdom Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20214
20222
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status3
Active, not recruiting1
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University College, London2
Barts & The London NHS Trust1
NHS Greater Glasgow and Clyde1
Queen's University, Belfast1
Royal Marsden NHS Foundation Trust1
Royal National Orthopaedic Hospital NHS Trust1
South Tees Hospitals NHS Foundation Trust1
University College London Hospitals1
University of Glasgow1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiotoxicity10
Neoplasms3
Cardiomyopathies2
Cardiovascular Diseases2
Atherosclerosis1
Breast Neoplasms1
Burkitt Lymphoma1
Colorectal Neoplasms1
Esophageal Neoplasms1
Gastrointestinal Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.